Ángela Lamarca

12.2k total citations · 5 hit papers
219 papers, 4.8k citations indexed

About

Ángela Lamarca is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Ángela Lamarca has authored 219 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Oncology, 104 papers in Surgery and 86 papers in Epidemiology. Recurrent topics in Ángela Lamarca's work include Cholangiocarcinoma and Gallbladder Cancer Studies (84 papers), Neuroendocrine Tumor Research Advances (81 papers) and Pancreatic and Hepatic Oncology Research (73 papers). Ángela Lamarca is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (84 papers), Neuroendocrine Tumor Research Advances (81 papers) and Pancreatic and Hepatic Oncology Research (73 papers). Ángela Lamarca collaborates with scholars based in United Kingdom, Spain and Italy. Ángela Lamarca's co-authors include Juan W. Valle, Mairéad G. McNamara, Richard Hubner, Jorge Barriuso, Lipika Goyal, Andrew X. Zhu, W. David J. Ryder, Julien Edeline, Melissa Frizziero and John Bridgewater and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ángela Lamarca

197 papers receiving 4.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New Horizons for Precision Medicine in Biliary Tract Cancers

2017 425 citations Juan W. Valle, Ángela Lamarca et al. profile →
Molecular targeted therapies: Ready for “prime time” in biliary tract cancer

2020 248 citations Ángela Lamarca, Mairéad G. McNamara et al. profile →
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

2023 190 citations Thierry Conroy, Per Pfeiffer et al. Annals of Oncology profile →
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes

2023 95 citations Johannes Hofland, Emanuel Christ et al. Journal of Neuroendocrinology profile →
Cholangiocarcinoma — novel biological insights and therapeutic strategies

2023 94 citations Ángela Lamarca et al. profile →

Peers

Countries citing papers authored by Ángela Lamarca

Since Specialization

Citations

This map shows the geographic impact of Ángela Lamarca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ángela Lamarca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ángela Lamarca more than expected).

Fields of papers citing papers by Ángela Lamarca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ángela Lamarca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ángela Lamarca. The network helps show where Ángela Lamarca may publish in the future.

Co-authorship network of co-authors of Ángela Lamarca

This figure shows the co-authorship network connecting the top 25 collaborators of Ángela Lamarca. A scholar is included among the top collaborators of Ángela Lamarca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ángela Lamarca. Ángela Lamarca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III randomized controlled trials 2025 ·European Journal of Cancer ·Erman Akkuş, Ángela Lamarca	3
2	SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025) 2025 ·Clinical & Translational Oncology ·(unknown), Jorge Adeva, (unknown), Ana Ruiz‐Casado, (unknown), Ángela Lamarca, (unknown), (unknown), Tamara Saurí, Javier Gállego	0
3	Facts and Hopes in the Systemic Therapy of Biliary Tract Carcinomas 2024 ·Clinical Cancer Research ·Ángela Lamarca, Teresa Macarulla	0
4	Management of non-hepatic distant metastases in neuroendocrine neoplasms 2023 ·Best Practice & Research Clinical Endocrinology & Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Luna, (unknown), (unknown), Ángela Lamarca	2
5	Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up breakdown → 2023 ·Annals of Oncology ·Thierry Conroy, Per Pfeiffer, Valérie Vilgrain, Ángela Lamarca, Thomas Seufferlein, Eileen M. O’Reilly, Thilo Hackert, Talia Golan, Gerald W. Prager, Karin Haustermans, Arndt Vogel, Michel Ducreux	190
6	94MO Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials 2023 ·Annals of Oncology ·Ángela Lamarca, Paul J. Ross, Harpreet Wasan, Richard Hubner, Mairéad G. McNamara, Andre Lopes, Daniel H. Palmer, Juan W. Valle, John Bridgewater	1
7	Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing 2023 ·Cancer Treatment Reviews ·Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Ángela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno	22
8	Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer 2023 ·Cancers ·Rille Pihlak, Melissa Frizziero, (unknown), (unknown), Ángela Lamarca, Richard Hubner, Juan W. Valle, Mairéad G. McNamara	3
9	Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre 2023 ·Healthcare ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ángela Lamarca, Richard Hubner, Juan W. Valle, Mairéad G. McNamara	2
10	Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma 2023 ·Current Oncology ·Victoria Foy, Mairéad G. McNamara, Juan W. Valle, Ángela Lamarca, Julien Edeline, Richard Hubner	1
11	The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients 2022 ·Journal of Neuroendocrinology ·Mauro Cives, Jorge Hernando, Ángela Lamarca, Catherine Bouvier, Martyn Caplin, Marianne Pavel	2
12	Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force) 2021 ·Journal of Neuroendocrinology ·Johannes Hofland, Ángela Lamarca, Richard P. Steeds, Christos Toumpanakis, Rajaventhan Srirajaskanthan, Rachel P. Riechelmann, Francesco Panzuto, Andrea Frilling, Timm Denecke, Emanuel Christ, Simona Grozinsky‐Glasberg, Joseph Davar, (unknown)	20
13	Clinical benefit of surveillance after resection of pancreatic ductal adenocarcinoma: A systematic review and meta-analysis 2021 ·European Journal of Surgical Oncology ·James Halle‐Smith, (unknown), Lois A. Daamen, James Hodson, Rupaly Pandé, Alastair L. Young, Nigel B. Jamieson, Ángela Lamarca, Hjalmar C. van Santvoort, I. Quintus Molenaar, Juan W. Valle, Keith Roberts	13
14	Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis 2021 ·Nature Communications ·Brian Y. Lee, Elizabeth Hogg, (unknown), Alexander Kononov, Adrián Blanco‐Gómez, (unknown), Jingshu Xu, Colin Hutton, Xiaohong Zhang, (unknown), Kenneth L. Beattie, Ángela Lamarca, Mairéad G. McNamara, Juan W. Valle, Claus Jørgensen	64
15	Impact of high tumor mutational burden in solid tumors and challenges for biomarker application 2020 ·Cancer Treatment Reviews ·Mairéad G. McNamara, Timothy W. Jacobs, Ángela Lamarca, Richard Hubner, Juan W. Valle, Eitan Amir	73
16	Clinical presentation, diagnosis and staging of cholangiocarcinoma 2019 ·Liver International ·Alejandro Forner, Gianpaolo Vidili, Marco Rengo, Luís Bujanda, Mariano Ponz‐Sarvisé, Ángela Lamarca	187
17	Capecitabine and Temozolomide in Patients with Advanced Pulmonary Carcinoid Tumours 2019 ·Neuroendocrinology ·George Papaxoinis, (unknown), (unknown), (unknown), Ángela Lamarca, Alison Backen, Daisuke Nonaka, Wasat Mansoor	27
18	Tumor Growth Rate as a Validated Early Radiological Biomarker Able to Reflect Treatment-Induced Changes in Neuroendocrine Tumors: The GREPONET-2 Study 2019 ·Clinical Cancer Research ·Ángela Lamarca, Maxime Ronot, Salma Moalla, Joakim Crona, (unknown), Carlos López, (unknown), (unknown), (unknown), (unknown), (unknown), Naïk Vietti Violi, (unknown), Louis de Mestier, (unknown), Éric Baudin, Anders Sundin, Frederico Costa, Marianne Pavel, Clarisse Dromain	22
19	A study of appendiceal crypt cell adenocarcinoma (so-called goblet cell carcinoid and its related adenocarcinoma) 2017 ·Human Pathology ·Daisuke Nonaka, George Papaxoinis, Ángela Lamarca, Paul Fulford, Juan W. Valle, Bipasha Chakrabarty	24
20	Mesenteric panniculitis as a first manifestation of Schönlein-Henoch disease 2010 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Ángela Lamarca, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact